Almac's Diagnostics business unit receives CAP lab accreditation

NewsGuard 100/100 Score

Almac's Diagnostics business unit has been awarded accreditation for its Craigavon, UK facilities by the Accreditation Committee of the College of American Pathologists (CAP), based on the results of a recent onsite inspection.

The laboratory's director, Richard Kennedy (MBChB, PhD) was advised of the national recognition and congratulated for the excellence of the service provided by Almac.

The CAP Laboratory Accreditation Program commenced in the early 1960s and is recognized by the federal government as being equal to or more stringent than the Government's own inspection program.

During the CAP accreditation process, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, along with the overall management of the lab. This stringent inspection program is designed to specifically ensure the highest standard of care for all laboratory patients.

President and Managing Director, Professor Paul Harkin commented on the achievement "This accreditation allows us to further support our clients by running clinical diagnostic tests for trial enrichment. This is of increasing importance to our clients and constitutes an important part of our biomarker services".

Source:

Almac

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Understanding long COVID: A call for better diagnosis and treatment